Alnylam Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Alnylam Pharmaceuticals Inc
CIK #0001178670
EDGAR Form CIK 2011 - 2026
10-K [0001178670]
10-Q [0001178670]
3 [0001178670]
4 [0001178670]
5 [0001178670]
8-K [0001178670]
SC 13G [0001178670]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Capital Management LLC Alnylam Pharmaceuticals Inc [2026-04-29]
Capital Research Global Investors Alnylam Pharmaceuticals Inc [2025-02-13]
Capital World Investors Alnylam Pharmaceuticals Inc [2022-09-09]
Price T Rowe Associates Inc /MD/ Alnylam Pharmaceuticals Inc [2022-02-14]
Baillie Gifford & Co Alnylam Pharmaceuticals Inc [2020-02-03]
Price T Rowe Associates Inc /MD/ Alnylam Pharmaceuticals Inc [2017-12-11]
BlackRock Inc Alnylam Pharmaceuticals Inc [2017-01-30]
Dodge & Cox Alnylam Pharmaceuticals Inc [2016-12-09]
Vanguard Group Inc Alnylam Pharmaceuticals Inc [2016-02-10]
BlackRock Inc Alnylam Pharmaceuticals Inc [2016-01-28]
View All
Form 3/4/5 Subject 2011 - 2026
Alnylam Pharmaceuticals Inc
Cravatt Benjamin
Pyott David E I
Reitan Colleen F
Schulman Amy W
Sigal Charles Elliott
Brandicourt Olivier
Hamburg Margaret A
Kellogg Peter N
Arbuckle Stuart A
Ausiello Dennis A
McLaughlin Melissa
Poulton Jeffrey V
Garg Pushkal
Tanguler Tolga
Fitzgerald Kevin Joseph
Greenstreet Yvonne
Supran Bryan
Bonney Michael W
Bertozzi Carolyn R
Hesslein Robert W
Sharp Phillip A
Franchini Indrani Lall
Vaishnaw Akshay
Fanucci Marsha
Paul Steven M
Maraganore John
Keating Laurie
Greene Barry E
Schimmel Paul
Soni Manmeet Singh
Sanofi
Mason Michael
Clarke John K
Starr Kevin P
Gros David-Alexandre C
Regulus Therapeutics Inc
Reid Laurence
Dzau Victor J
Novartis Pharma AG
Novartis AG
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-05 Sell 124 $321.81 39,904
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-05 Sell 153 $326.24 49,915
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-05 Sell 740 $323.55 239,427
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-05 Sell 148 $324.60 48,041
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-05 Sell 654 $322.33 210,804
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-05 Sell 510 $324.59 165,541
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-05 Sell 500 $326.08 163,040
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-05 Sell 233 $323.25 75,317
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-04 Sell 374 $323.01 120,806
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-04 Sell 368 $321.82 118,430
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-04 Sell 208 $325.67 67,739
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-04 Sell 444 $323.01 143,416
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-04 Sell 102 $320.01 32,641
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-04 Sell 272 $324.88 88,367
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-04 Sell 75 $324.88 24,366
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-04 Sell 106 $319.03 33,817
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-04 Sell 102 $320.01 32,641
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-04 Sell 29 $319.03 9,252
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-04 Sell 973 $323.84 315,096
Alnylam Pharmaceuticals Inc ALNY
Common Stock
2026-03-04 Sell 59 $320.81 18,928
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com